https://www.live-feeds.com/feed/roche-inks-1-2b-deal-with-china-s-rona-to-enter-emerging-alk7-obesity-raceContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/roche-inks-1-2b-deal-with-china-s-rona-to-enter-emerging-alk7-obesity-racehttps://www.live-feeds.com/feed/roche-inks-1-2b-deal-with-china-s-rona-to-enter-emerging-alk7-obesity-race#u126837Sat, 17 Oct 2026 05:45:50 +0000Roche has entered into a licensing agreement with China's Rona Therapeutics for an obesity therapy, with the deal potentially worth up to $1.2 billion. The partnership grants Roche access to Rona's genetic obesity approach, specifically targeting ALK7. This move expands Roche's presence in the emerging obesity treatment market.Why it mattersThe deal is part of Roche's strategy to bolster its research and development footprint in obesity treatment. Obesity is a growing health concern globally, and pharmaceutical companies are actively seeking innovative solutions. The partne